Results 21 to 30 of about 63,135 (308)

Modern hormonal contraceptives

Гинекология, 2017
По материалам симпозиума «Женское здоровье и контрацепция» В сентябре 2017 г. состоялся ставший традиционным XVIII Всероссийский научно-образовательный форум «Мать и дитя».
- -
doaj   +1 more source

Ovarian function during hormonal contraception assessed by endocrine and sonographic markers: a systematic review [PDF]

, 2016
This systematic review focuses on the literature evidence for residual ovarian function during treatment with hormonal contraceptives. We reviewed all papers which assessed residual ovarian activity during hormonal contraceptive use, using endocrine ...
Bastianelli, Carlo, Candelieri, Miriam, D'Arpe, Stella, DI FELICIANTONIO, Mara, Franceschetti, Silvia, Piccioni, Maria Grazia   +5 more
core   +1 more source

Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa

Bulletin of the World Health Organization, 2012
OBJECTIVE: To estimate the potential impact of using hormonal contraceptives on rates of infection with human immunodeficiency virus type 1 (HIV-1) and pregnancy by theoretically removing the use of hormonal contraceptives from a study population ...
Gita Ramjee, Handan Wand
doaj   +1 more source

The progestogen content of combined oral contraceptives and venous thromboembolic risk [PDF]

, 2011
Peer ...
Hannaford, Philip C
core   +1 more source

Anti-müllerian hormone is not associated with cardiometabolic risk factors in adolescent females [PDF]

, 2013
<p>Objectives: Epidemiological evidence for associations of Anti-Müllerian hormone (AMH) with cardiometabolic risk factors is lacking. Existing evidence comes from small studies in select adult populations, and findings are conflicting. We aimed to
A Bayrak, A La Marca, A La Marca, A Piouka, Abigail Fraser, AC Hergenroeder, AM Wallace, Andrea Cignarella, AZ Steiner, B Schwartz, BC Gladen, C Levy-Marchal, C Mattocks, C Villarroel, CJ Riddoch, CP Hagen, CP Hagen, Debbie A. Lawlor, E Buyuk, E Codner, EB Johnstone, Emma L. Anderson, EW Freeman, FB Hu, GF Kerkhof, GS Berenson, Hany Lashen, HM Blanck, HT Park, HY Woo, IA van Rooij, JC Rockett, JM Raitakari OT, JP Strong, KR Hansen, L Aksglaede, LG Nardo, M Hickey, M Juonala, MC Chu, MJ Chen, N Gungor, N Morris, Naveed Sattar, P McCarron, P Skalba, R Fleming, R Hart, Richard Fleming, RL Thomson, S Palomba, Scott M. Nelson, SM Nelson, T Freour, T Kelsey, T Sir-Petermann, TW Kelsey, WA Marshall, William McNally, WJK Hehenkamp, WT Friedewald, YH Lin, YT van der Schouw   +62 more
core   +9 more sources

Comparative description of the use of modern methods of hormonal contraception for women with excessive body mass

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2016
Maintenance of reproductive health of women with excessive weight is the actual problem of nowadays and is an important direction of modern medicine. Aim.
I. B. Gridina
doaj   +1 more source

Use of depot medroxyprogesterone acetate and fracture risk [PDF]

, 2010
Depot medroxyprogesterone acetate (DMPA), which has a high rate of use among teenagers in Europe and the United States, has been associated with impaired bone mineral acquisition during adolescence and accelerated bone loss in later life.
Brauchli, Yolanda B., Jick, Susan S., Kraenzlin, Marius E., Meier, Christian, Meier, Christoph R.   +4 more
core   +1 more source

Long-Acting Hormonal Contraception [PDF]

Women's Health, 2015
Today, a new category of fertility-regulating agents has been created: long-acting, reversible hormonal contraceptives; they minimize compliance, while maximize effectiveness. They comprise subdermal implants and intrauterine devices. Other long-acting agents exist, such as Depo Provera and Noristerat.
Giuseppe Benagiano, Henry Gabelnick, Ivo Brosens   +2 more
openaire   +3 more sources

Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis. [PDF]

PLoS Med, 2023
Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V.   +4 more
europepmc   +2 more sources

Would male hormonal contraceptives affect cardiovascular risk?

Asian Journal of Andrology, 2018
The aim of hormonal male contraception is to prevent unintended pregnancies by suppressing spermatogenesis. Hormonal male contraception is based on the principle that exogenous administration of androgens and other hormones such as progestins suppress ...
Michael Zitzmann
doaj   +1 more source